Accelerating Safe Access to
Longevity & Regenerative Therapies
The LARTA Ecosystem is a public-private partnership between the Government of The Bahamas and the LARTA Agency
Register HereThe LARTA Ecosystem
The government's Longevity and Regenerative Therapies Unit grants ethics approvals and licenses for longevity and regenerative therapy programs. The LARTA Agency, exclusively mandated by the Ministry of Health & Wellness, manages all applications through its digital portal and supports companies in navigating the regulatory process.
Through the LARTA Agency, every applicant follows a unified pathway for licensing, research protocols, and compliance. Our framework guarantees that therapies in The Bahamas are held to uncompromising standards of safety, ethical integrity, and scientific excellence.
Longevity & Regenerative Therapies in The Bahamas
The 2024 Longevity and Regenerative Therapies Act (LARTA) fosters global research, innovation, and access to regenerative, holistic, and functional therapies that have demonstrated safety, scientific merit, high-quality management, and the ability to be ethically delivered.
Education and Workforce Development: Building The Bahamas' Capacity for Advanced Medicine
The Future of Medical Tourism: LARTA Agency's Role in Advancing Healthcare Access
Regulatory Innovation: Comparing International Frameworks for Advanced Therapeutics
Economic Impact of Longevity Medicine: How Advanced Therapies Drive Growth in The Bahamas
Building Trust in Advanced Therapies: LARTA's Commitment to Patient Safety and Ethical Oversight
The Science Behind Longevity Medicine: Understanding Advanced Therapeutic Approaches
Digital Innovation in Medical Regulation: How LARTA's Platform is Transforming Healthcare Oversight
Understanding the Longevity and Regenerative Therapies Act
The LARTA
Agency Services
The LARTA Agency was established to guarantee The Bahamas' transformation into a global hub for safe, ethical and accessible longevity and regenerative therapies
Our integrated pillars work together to create a seamless journey from regulatory approval to patient impact, all while maintaining the highest standards of safety and efficacy.
Patient Safety & Ethical Access
Patient safety is at the heart of the LARTA system. Every therapy and research protocol undergoes rigorous ethical review and oversight to ensure that access to longevity and regenerative medicine is delivered responsibly. Strict guidelines and continuous monitoring protect participants, uphold informed consent, and guarantee that all interventions meet the highest ethical standards.
Efficacy-Focused Follow-Up Data
Ongoing evaluation is essential to measure the real-world effectiveness of therapies. LARTA requires comprehensive follow-up data collection and analysis for every approved protocol, enabling continuous assessment of outcomes. This focus on transparency and efficacy ensures that patients, providers, and regulators have access to reliable information on the benefits and risks of each therapy.
LARTA
Ecosystem Pillars
Scientific Merit & Evidence-Driven
All therapies proposed for Investigator-Initiated Trials (IITs) under LARTA must undergo rigorous scientific and ethical evaluation. Each submission is subject to independent expert review to confirm that only evidence-based approaches advance, supported by robust data, transparent methodologies, and adherence to ICH-aligned international best practices. This process ensures that trials conducted through LARTA maintain the highest levels of integrity, regulatory credibility, and scientific excellence, reinforcing The Bahamas’ standing as a trusted hub for longevity and regenerative medicine.
Quality Control
Quality control is embedded throughout the LARTA process. From initial application to post-treatment reporting, every step is subject to strict standards and independent oversight. This ensures that all therapies and research activities maintain consistency, reliability, and excellence-reinforcing The Bahamas' reputation as a trusted destination for longevity and regenerative medicine.
All-in-One Partner in
Optimizing Health Span
Biotech & Medtech Companies
Physicians & Researchers
Longevity Therapy Patients
Biotech and Medtech companies that have a technology or therapies that demonstrated safety in humans, seeking accelerated in-patient therapies paths
Medical professionals exploring cutting-edge treatment options for patients
Individuals and companies seeking breakthrough regenerative treatments
Delivering priority access to regulatory guidance and license application, investment matchmaking, and strategic partnerships within The Bahamas' innovative framework.
Access to cutting-edge research collaborations, approved real-world evidence data, and opportunities to participate in groundbreaking trials.
With personalized health tracking, educational resources, and exclusive marketplace of cutting-edge therapies.
Learn about The Bahamas' groundbreaking Longevity and Regenerative Therapies framework, new and innovative therapies, key industry events, and more.
